If true, this suggests that neuroendocrine tumors that produce one or more RSPOs and Lgr4/5/6 would not downregulate Sstr2 expression, even if they are expressing significant levels of Wnt ligands. This evidence concerns the gene LGR4 and neuroendocrine neoplasm.